Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina
Open Access
- 29 May 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Lipids in Health and Disease
- Vol. 13 (1), 89
- https://doi.org/10.1186/1476-511x-13-89
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stentingCardiovascular Diabetology, 2012
- High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)Cardiovascular Diabetology, 2012
- Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysisCardiovascular Diabetology, 2011
- Threshold Haemoglobin Levels and the Prognosis of Stable Coronary Disease: Two New Cohorts and a Systematic Review and Meta-AnalysisPLoS Medicine, 2011
- Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetesCardiovascular Diabetology, 2011
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk FactorsDiabetes Care, 2010
- Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular DiseaseDiabetes Care, 2010
- Comparison of Plasminogen Activator Inhibitor-1, Tissue Type Plasminogen Activator Antigen, Fibrinogen, and D-Dimer Levels in Various Age Decades in Patients With Type 2 Diabetes Mellitus and Stable Coronary Artery Disease (from the BARI 2D Trial)The American Journal of Cardiology, 2010
- Uric acid and inflammatory markersEuropean Heart Journal, 2006